General Methods

General Materials and Chemical Reagents
All amino acid building blocks for peptide synthesis and chemicals were purchased from Sigma Aldrich (Oakville, ON). Fmoc-rink amide-MBHA resins were purchased from Ana Spec (Fremont, CA). 1% Picrylsulfonic acid in DMF solution used for primary amine test was purchased from Sigma Aldrich (Oakville, ON). UDP-glucose was purchased from Sigma Aldrich (Oakville, ON). Organic solvents used for peptide synthesis and HPLC were purchased from Sigma Aldrich (Oakville, ON). Restriction enzymes and quick-stick ligase were purchased from New England Biolabs (Mississauga, Ontario) . QIA mini prep kit was purchased from New England Biolabs (Mississauga, Ontario) . Amylose resin was purchased from New England Biolabs (Mississauga, Ontario) . Protease Inhibitor Cocktail pellet was purchased from Roche Diagnostics (Laval, Quebec).
General Instruments
The MALDI spectra were taken using a Waters Micromass MALDI micro MX™ (matrixassisted laser/desorption/ionization time-of-flight mass spectrometer [MALDI-ToF MS]) using α-cyano-4-hydroxycinnamic acid matrix. UV absorption was measured on either a Shimadzu UV-2401 PC spectrophotomether or a Nanodrop ND_1000. Semi-preparative HPLC separations were performed on a Waters 1525 Binary HPLC pump and Waters 2487 dual λ absorption detector using a Waters XBridgeTM Prep BEH130 C18 5 μm (10 × 250 mm) reverse phase column. Protein mass spectra were obtained from an ABI/Sciex QStar mass spectrometer fitted with a desalting column prior to direct introduction into the ESI source. 19 F NMR spectra were recorded on an Agilent DD2-700 MHz spectrometer.
Solid-Phase Peptide Synthesis
Peptide synthesis (Scheme 1)
All peptides in this paper were synthesized on Fmoc-rink amide-MBHA resin using Fmoc-SPPS chemistry. Each peptide was synthesized on a scale of 0.1 mmol if not specified. Scheme S1. General peptide synthesis procedure
Peptide purification
The crude peptides were dissolved in DMF and purified by semi-preparative RP-HPLC (XBridge Prep BEH 130 C 18, 10×250 mm). The purification condition of each peptide is shown in Table 1 and Table 2 . HPLC fractions corresponding to the desire peptide were confirmed by MALDI. The peptide concentration was quantified by the UV absorption in 0.02 M phosphate buffer (6M guanidine hydrochloride, pH6.5) using an extinction coefficient that was calculated from ProtParam tool. Peptides were stored in DMSO at -20 ºC. Table S1 . HPLC gradient Table S2 . Peptide HPLC purification methods
MALDI Kinetics
Peptide glucosylation reaction
Peptide (various concentrations, maximum DMSO concertation 20%, Enzyme activity was not substantially affected by DMSO at this concentration) was incubated with Toxin B (2 µM, or 5 µM, or 10 µM) and an excess UDP-glucose (10 mM) buffer (50 mM HEPES, 100 mM KCl, 2 mM MgCl 2 , 1 mM MnCl 2 , pH 7.5) at 37°C for 4 hours. Aliquots of the reaction mixture (10 µL) were taken at 15 min, 30 min, 1hr, 2hr, and 4 hr time points.
Immediately after removing the samples they were loaded and desalted on a C18 ZipTip using an 50/50 acetonitrile/water eluent. A sample (~2 µL) was then spotted onto a crystallized CHCA matrix spot on the MALDI plate. The averaged MALDI spectrum was obtained by collecting 60 to 100 shots across the sample.
Mechaelis Menten fitting of peptide substrates
The glycosylation rate was calculated by the formula (Figure % = + S1). From velocity vs peptide concentration plots the K m and k cat values were determined by fitting with Graph Pad Prism 6 ( Figure S2 ). elution was followed at 215 nm to determine ratio of starting peptide to glucosylated peptide for kinetic analysis. The HPLC gradient used was Method A in Table S2 . The HPLC results of 2 glucosylation was shown in Figure S3 . The % of glycosylation was calculated by The initial velocities calculated from MALDI % = + .
and HPLC are agree within 10% ( Figure S3 c & d, and g & h) . Plasmids were verified by sequencing and then transferred to E. coli BL21 for expression.
Construction of plasmids encoding C-terminal MBP-tag fusions.
Oligonucleotides were designed so that complimentary pairs contained overhanging sequence that could anneal with NdeI/SalI digested pCWmalE-thrombin (REF Figure S4 ) and the purified proteins were combined, purified through P10 column, and further concentrated by Amicon Ultra.
Expression and purification
Protein concentration was determined by UV absorption based on the theoretical extinction coefficient. Final protein was stored in -20 °C. Figure S4 . SDS-PAGE of purified MBP-tagged protein (construct 2). 
MBP-tagged protein sequences
Glucosylation of MBP-tagged proteins
The MBP-tagged protein (100 µM) was incubated with Toxin B (10 µM) and UDP-Glucose (10 mM) in reaction buffer (50 mM HEPES, 100 mM KCl, 2 mM MgCl 2 , 1 mM MnCl 2 , pH 7.5) at 37°C overnight. The resulted glucosylation reaction was monitored by ESI ( Figure   S5 ). 
